The Antibody Society’s Board of Directors is a governing body with a fiduciary duty to further the best interests of the Society, and to oversee the conduct of the Society activities, supervise the Executive Committee, and set the standards of conduct and performance for the Society. Board directors:
- Represent the Society to the community
- Attract volunteers
- Engage corporate sponsors
- Assist with publicity
- Participate with strategic planning and budgeting
- Ensure smooth operation of the Society
|Paul Carter, Ph.D.
||Kerry A. Chester, Ph.D.|
|Mitchell Ho, Ph.D.*||
Nina Luning Prak, M.D., Ph.D.
|Paul W.H.I. Parren, Ph.D.
|Janice M. Reichert, Ph.D.
|Janine Schuurman, Ph.D.
Vice President, 2022-3
*Dr. Mitchell Ho serves as a federal liaison.
Clerk of The Antibody Society: Pamela Borghardt
The Founding Board of Directors
The first annual meeting of The Antibody Society’s Board of Directors was held on December 2, 2007, following an organizational meeting held on May 22, 2007. The founding board members were:
|Andrew Bradbury, M.B., B.S., Ph.D.||Dennis R. Burton, Ph.D.|
|James Marks, Ph.D.||
Andreas Plückthun, Ph.D.
|Jamie Scott, M.D., Ph.D.||Louis M. Weiner, M.D.|